News for 'SARS'

Why is Delta variant so dominant?

Why is Delta variant so dominant?

Rediff.com7 Sep 2021

The international team of researchers combined lab-based experiments and epidemiology of vaccine breakthrough infections, showing that the Delta variant is better at replicating and spreading than other commonly-observed variants.

How monkeys were tracked for Covaxin trial

How monkeys were tracked for Covaxin trial

Rediff.com14 Nov 2021

The Rhesus macaque monkeys, used worldwide in medical research, are believed to be the best non-human primates for such studies.

Repeat Covid infections increase organ failure, death risk: Study

Repeat Covid infections increase organ failure, death risk: Study

Rediff.com11 Nov 2022

The study also indicated that the risk seems to increase with each infection.

Covishield, Covaxin get regular market approval

Covishield, Covaxin get regular market approval

Rediff.com27 Jan 2022

Under the conditions, the firms shall submit data of ongoing clinical trials and the vaccines to be supplied for programmatic setting.Adverse event following immunisation will continue to be monitored.

Researchers develop new N95 mask that can curb Covid spread, kill virus

Researchers develop new N95 mask that can curb Covid spread, kill virus

Rediff.com4 Jul 2022

The mask can potentially be worn longer, causing less plastic waste as it does not need to be replaced as frequently, the researchers said.

COVID-19: How The RAT Can Help

COVID-19: How The RAT Can Help

Rediff.com2 Feb 2022

'Serial testing is much more valuable than a single test which reflects just a point in time.'

Men more likely to suffer severe effects of COVID-19 than women: Study

Men more likely to suffer severe effects of COVID-19 than women: Study

Rediff.com29 Apr 2020

Based on the observations, scientists said that additional care may be required for older men or those with underlying conditions. Yang and his team analysed several patient datasets to see if there were differences in how men and women respond to COVID-19.

Study says coronavirus infects heart cells of patients

Study says coronavirus infects heart cells of patients

Rediff.com1 Jul 2020

"We not only uncovered that these stem cell-derived heart cells are susceptible to infection by novel coronavirus, but that the virus can also quickly divide within the heart muscle cells," said study co-author Arun Sharma from the Cedars-Sinai Board of Governors Regenerative Medicine Institute in the United States. "Even more significant, the infected heart cells showed changes in their ability to beat after 72 hours of infection," Sharma said.

Study comparing Covishield, Covaxin has limitations: Bharat Biotech

Study comparing Covishield, Covaxin has limitations: Bharat Biotech

Rediff.com9 Jun 2021

Raches Ella, project lead, Covid-19 vaccines at Bharat Biotech said in a series of tweets that he was 'surprised' that media and researchers were drawing conclusions based on non-peer reviewed work.

Experts downplay apprehensions centred around Covid XE

Experts downplay apprehensions centred around Covid XE

Rediff.com7 Apr 2022

Experts said the strain has not propelled a surge in cases like Omicron, but advised strict adherence to COVID-19-appropriate behaviour.

Maha to withdraw all Covid curbs from April 2, masks not compulsory

Maha to withdraw all Covid curbs from April 2, masks not compulsory

Rediff.com31 Mar 2022

The decision was taken at a cabinet meeting chaired by Chief Minister Uddhav Thackeray, Health Minister Rajesh Tope told reporters.

This Diwali, 'light up your lives with positivity'

This Diwali, 'light up your lives with positivity'

Rediff.com3 Nov 2021

Bollywood stars celebrate Diwali with beautiful pictures.

NTAGI mulls 'additional' Covid jab for immunocompromised

NTAGI mulls 'additional' Covid jab for immunocompromised

Rediff.com5 Dec 2021

According to officials, an additional dose of vaccine is different from a booster dose.

SARS hits grey PC market

SARS hits grey PC market

Rediff.com5 May 2003

Problems related to bones, muscles persist post Covid

Problems related to bones, muscles persist post Covid

Rediff.com12 Oct 2021

The systemic inflammatory response to SARS-CoV-2 adversely impacts the musculoskeletal system. Inflammatory molecules break the muscle fiber protein and decrease muscle protein synthesis leading to decreased muscle strength and also weaken bones.

4 detected with SA Covid variant, 1 with Brazil strain: Govt

4 detected with SA Covid variant, 1 with Brazil strain: Govt

Rediff.com16 Feb 2021

All travellers and contacts have been tested and quarantined.

Omicron: States told to step up testing; curbs extended till Dec 31

Omicron: States told to step up testing; curbs extended till Dec 31

Rediff.com30 Nov 2021

Union health secretary Rajesh Bhushan held a review meeting with states and Union Territories on Tuesday and advised them to ramp up testing for early identification and management of cases.

Tragedy at sea: 26 dead, 49 missing from barge; 186 rescued

Tragedy at sea: 26 dead, 49 missing from barge; 186 rescued

Rediff.com19 May 2021

The navy had so far maintained that there were 273 persons on board the barge but an official on Wednesday evening said that the company which operated it has informed that there were 261 personnel on board the ill-fated barge.

Omicron risk remains 'very high', says WHO

Omicron risk remains 'very high', says WHO

Rediff.com29 Dec 2021

The weekly epidemiological update by WHO revealed the week of December 20-26 saw the global number of new COVID-19 cases increase by 11 per cent as compared to the previous week.

Ahead of Covid vaccine rollout, Centre issues dos and don'ts

Ahead of Covid vaccine rollout, Centre issues dos and don'ts

Rediff.com14 Jan 2021

In a letter to all states and Union territories, the ministry highlighted that under the emergency use authorisation, coronavirus vaccination is indicated only for 18 years and above. If required, COVID-19 vaccine and other vaccines should be separated by an interval of at least 14 days.

Covid infection is not severe in kids, send them to school: Dr Gagandeep Kang

Covid infection is not severe in kids, send them to school: Dr Gagandeep Kang

Rediff.com31 Dec 2021

"In children, fortunately, infections with SARS-CoV-2 are generally not severe. There is a risk of long COVID, there is a risk of a very, very rare condition called MISC (Multisystem Inflammatory Syndrome) but by and large healthy children have nothing," said Dr Gagandeep Kang, leading Indian virologist.

Indian Covid variant found in 44 countries: WHO

Indian Covid variant found in 44 countries: WHO

Rediff.com12 May 2021

The coronavirus variant B.1.617 first identified in India last year has been classified as a "variant of global concern", with some preliminary studies showing that it spreads more easily, a senior WHO official had said on Monday.

SAR Geelani's CRPP a Maoist front: Government

SAR Geelani's CRPP a Maoist front: Government

Rediff.com7 Dec 2011

The reference to CRPP as a Maoist front organisation came in a written reply in Rajya Sabha by Jitendra Singh, Minister of State for Home Affairs.

Distinct trait found in coronavirus in India

Distinct trait found in coronavirus in India

Rediff.com4 Jun 2020

They have named this unique cluster of virus population as 'Clade A3i' found in 41 per cent of the genome sequenced in India.

'COVID-19 can quietly enter your body, without causing pain'

'COVID-19 can quietly enter your body, without causing pain'

Rediff.com3 Dec 2020

'The COVID-19 virus has the power to quietly enter your body, without causing pain via symptoms, because it craftily manipulates your pain response.'

Covishield booster works against Omicron

Covishield booster works against Omicron

Rediff.com24 Dec 2021

If the vaccine is recommended for use as a booster against Omicron, it may significantly boost the demand for Covishield in India.

Covaxin's 50 pc efficacy adequate for Covid, say experts

Covaxin's 50 pc efficacy adequate for Covid, say experts

Rediff.com26 Nov 2021

The decline in the effectiveness of Covaxin, India's indigenous COVID-19 vaccine, from 77.8 per cent to 50 per cent during a Delta-driven case surge in April and May this year is neither bad nor surprising, say scientists.

WFI chief Singh to step aside, wrestlers call off protest

WFI chief Singh to step aside, wrestlers call off protest

Rediff.com21 Jan 2023

The government decided to form an oversight committee which will investigate the allegations of sexual harassment of women wresters by WFI president Brij Bhushan Sharan Singh.

Cold, Flu Or COVID-19? Know The Difference

Cold, Flu Or COVID-19? Know The Difference

Rediff.com24 Jan 2022

Dr Karthiyayini Mahadevan tells you how to differentiate between a cold, flu and COVID-19 and take appropriate action.

WHO clears Serum Institute's Covovax for emergency use

WHO clears Serum Institute's Covovax for emergency use

Rediff.com18 Dec 2021

'WHO issued an emergency use listing for Covovax, expanding the basket of WHO-validated vaccines against COVID-19. The vaccine is produced by the Serum Institute of India under licence from Novavax,' the world health body said in a tweet on Friday.

How to DEFEAT the NEXT Pandemic

How to DEFEAT the NEXT Pandemic

Rediff.com3 Nov 2021

Illustrious international thinkers met at the Milken Institute Global Conference 2021 and many discussions addressed the impact of the COVID-19 pandemic on the world at large.

2 gorillas at US zoo test positive for COVID-19

2 gorillas at US zoo test positive for COVID-19

Rediff.com17 Jan 2021

According to the zoo, two of the gorillas had started coughing on Wednesday, following which San Diego Zoo Global initiated the process of testing fecal samples from them for SARS-CoV-2 through the California Animal Health and Food Safety Laboratory System.

'COVID-19 vaccine will be made in India'

'COVID-19 vaccine will be made in India'

Rediff.com12 Jun 2020

'I can say with confidence that any future SARS-CoV-2 vaccine, developed anywhere in the world, would have to be manufactured in India, if it is to be affordable and of high quality.'

With Axar yet to recover, Delhi Capitals induct Mulani

With Axar yet to recover, Delhi Capitals induct Mulani

Rediff.com15 Apr 2021

Delhi Capitals have brought in Shams Mulani as a short-term COVID-19 replacement for Axar Patel for their IPL-2021 campaign.

HSBC, StanChart processed trillions of dollars in suspicious funds: Report

HSBC, StanChart processed trillions of dollars in suspicious funds: Report

Rediff.com21 Sep 2020

Some of the world's biggest banks including HSBC, JPMorgan Chase and Standard Chartered moved trillions of dollars identified as being potentially tied to money laundering or other crimes despite raising concerns about those transactions in filings with US regulators, reports South China Morning Post.

Full Text: PM Modi's address to US Congress

Full Text: PM Modi's address to US Congress

Rediff.com23 Jun 2023

Here's the full text of Prime Minister Narendra Modi's address to a joint session of the United States Congress, delivered on Thursday.

Delta Plus variant: Govt alerts 8 states, UTs

Delta Plus variant: Govt alerts 8 states, UTs

Rediff.com25 Jun 2021

The Union health ministry on Friday urged eight states and Union Territories to take up immediate containment measures including preventing crowds, conducting widespread testing as well as increasing vaccine coverage on a priority basis in districts where the Delta Plus variant of coronavirus has been detected.

Recovered people showing faster response to Covishield: Study

Recovered people showing faster response to Covishield: Study

Rediff.com3 Mar 2021

Those who have recovered from COVID-19 respond faster to the Covishield vaccine and reach high antibody levels, says a study, leading to hopes that they may not need a second dose and therefore help widen India's corona immunisation cover.

What India needs to do to avert China-like Covid surge

What India needs to do to avert China-like Covid surge

Rediff.com28 Dec 2022

"Provide enough infrastructure and money to carry out surveillance and set up a robust routine surveillance machinery for the country to monitor any and every infectious disease'